New Cancer Drug Offers Hope, At a High Price Tag

The first of a promising new class of cancer drugs went on sale in Japan this week at an average annual cost of $143,000 a patient, a harbinger of hefty prices the drugs are expected to command in the U.S. and Europe.



from WSJ.com: US Business http://ift.tt/1BcpnjI

via IFTTT